Takeuchi A. : The transmitter role of glutamate in nervous systems. Jpn J Physiol1987;37:559-572.
11.
Bradford HF , Bennett GW, Thomas AJ: Depolarizing stimuli and the release of physiologically active amino acids from suspensions of mammalian synaptosomes. J Neurochem1973; 21:495-505.
12.
Wofsey AR, Kuhar MJ, Snyder SH: A unique synaptosomal fraction which accumulates glutamic and aspartic acids in brain tissue. Proc Natl Acad Sci( USA ) 1971;68:1102-1106.
Lucas DR, Newhouse JP: The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol1957;58:193-201.
15.
Olney JW: Glutamate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol1969;28:455-474.
16.
Olney JW: Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science1969;164: 719-721.
17.
Olney JW, Ho OL: Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature1970;227:609-610.
18.
Burde RM, Schainker B., Kayes J.: Monosodium glutamate: Acute effect of oral and subcutaneous administration on the arcuate nucleus of the hypothalamus in mice and rats. Nature1971;233:58.
19.
Olney JW: Glutamate-induced neuronal necrosis in the infant mouse hypothalamus: An electron microscopic study. J Neuropathol Exp Neurol1971;30:75-90.
Olney JW, Ho OL, Rhee V.: Cytotoxic effects of acidic and sulphur-containing amino acids on the infant mouse central nervous system. Exp Brain Res1971;14:61-76.
22.
Watkins JC: Excitatory amino acids, in McGeer E, Olney JW, McGeer P (eds): Kainic Acid as a Tool in Neurobiology. New York, Raven Press, 1978, pp 37-69.
23.
Olney JW, deGubareff T., Labruyere J.: α-Aminoadipate blocks the neurotoxic action of N-methylaspartate . Life Sci1979;25: 537-540.
24.
Olney JW, Labruyere J., Collins JF, Curry K.: D-Aminophosphonovalerate is 100-fold more powerful than D-alphaaminoadipate in blocking N-methylaspartate neurotoxicity. Brain Res1981;221:207-210.
25.
Olney JW, Price MT, Fuller TA, et al: The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics. Neurosci Lett1986 ;68:29-34.
26.
Olney J., Price M., Shahid Salles K, et al: MK-801 powerfully protects against N-methyl aspartate neurotoxicity . Eur J Pharmacol1987;141:357-361.
27.
Choi DW, Koh J., Peters S.: Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J Neurosci1988;8:185-196.
28.
Olney JW, Price MT, Labruyere J., et al: Anti-parkinsonian agents are phencyclidine agonists and N-methyl aspartate antagonists. Eur J Pharmacol1987 ;142:319-320.
29.
Lodge D., Anis NA: Effects of phencyclidine on excitatory amino acid activation of spinal interneurons in the cat. Eur J Pharmacol1982 ;77:203-204.
30.
Lodge D., Aram JA, Church J., et al: Excitatory amino acids and phencyclidine-like drugs, in Hicks TP, Lodge D, McLennan H (eds): Excitatory Amino Acid Transmission. New York, Alan R. Liss, 1987.
31.
Goldberg MP , Pham P., Choi DW: Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture. Neurosci Lett1987;80:11-15.
Price MT, Honore T., Mueller ME, et al: CNQX potently and selectively blocks kainate excitotoxicity in the chick embryo retina. Neurosci Abstr1988;14:418.
34.
Rothman SM: Excitatory amino acid neurotoxicity is produced by passive chloride influx . Neurosci1985;6:1483-1489.
35.
Olney JW, Price MT, Samson L., Labruyere J.: The role of specific ions in glutamate neurotoxicity. Neurosci Lett1986;65:65-71
36.
Choi DW: Glutamate neurotoxicity in cortical cell culture is calcium dependent . Neurosci Lett1985;58:293-297.
37.
Excitatory amino acids in the brain—focus on NMDA receptors . TINS1987;10(Special Issue):263-302.
38.
Olney JW: Excitotoxic food additives—Relevance of animal studies to human safety . Neurobehav Toxicol Teratol1984;6:455-462.
39.
Olney JW: Food additives, excitotoxic, in Adelman G (ed): Encyclopedia of Neuroscience. Boston, Birkhauser, 1987, pp 436-438.
40.
Spencer PS, Ludolph A., Dwived MP, et al: Lathyrism: Evidence for role of the neuroexcitatory aminoacid BOAA. Lancet1986;2:1066-1067.
41.
Spencer PS , Nunn PB, Hugon J., et al: Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science1987 ;237:517-522.
42.
Olney JW, Misra CH, deGubareff T.: Cysteine-S-sulfate: Brain damaging metabolite in sulfite oxidase deficiency . J Neuropathol Exp Neurol1975;34:167-176.
43.
Plaitakis A. , Berl S., Yahr M.: Neurological disorders associated with deficiency of glutamate dehydrogenase . Ann Neurol1984 ;15:144-153.
44.
Plaitakis A. , Caroscio JT: Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol1987;22:575-579.
45.
Auer RN, Kalimo H., Olsson Y., Wieloch T.: The dentate gyrus in hypoglycemia. Pathology implicating excitotoxin-mediated neuronal necrosis. Acta Neuropathol(Berl ) 1985;67:279-288.
46.
Olney JW, Collins RC, Sloviter RS: Excitotoxic mechanisms of epileptic brain damage, in Delgado-Escueta AV, Ward AA, Woodbury DM, Porter RJ (eds): Basic Mechanisms of the Epilepsies: Molecular and Cellular Approaches, New York, Raven Press, 1986, pp 857-878.
47.
Ikonomidou C., Price MT, Mosinger JL, et al: Hypobaricischemic conditions produce glutamate-like cytopathology in infant rat brain. J Neurosci1989, in press.
48.
Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage . Ann Neurol1986;19:105-111.
Clifford DB , Benz A., Olney JW, Zorumski CF: MK-801 prevents seizure-related brain damage from pilocarpine and lithium-pilocarpine epidural well seizures . Soc Neurosci Abstr1988;14:417.
51.
Wieloch T.: Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science1985;230:681-683.
52.
Katayama Y. , Cheung MK, Gorman L., et al: Increase in extracellular glutamate and associated massive ionic fluxes following concussive brain injury. Soc Neurosci Abstr1988;14: 1154.
53.
Hayes RL, Chapouris R., Lyeth BG, et al: Pretreatment with phencyclidine (PCP) attenuates long-term behavioral deficits following concussive brain injury in the rat. Soc Neurosci Abstr1987;13:1254.
54.
Faden AI, Simon RP: N-methyl-D-aspartate receptor antagonist MK-801 improves outcome following experimental spinal cord injury in rats. Neurosci Abstr1987;13:1031.
55.
Silverstein FS, Buchanan K., Johnston MV: Perinatal hypoxia-ischemia disrupts striatal high affinity [3H]-glutamate uptake into synaptosomes. J Neurochem1986;47:1614-1619.
56.
Benveniste H., Drejer J., Schousboe A., Diemer NM: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis . J Neurochem1984;43:1369-1374.
57.
McDonald JW , Silverstein FS, Johnston MV: MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol1987;140:359-361.
58.
McDonald JW , Silverstein FS, Johnston MV: Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res1988;459:200-203.
59.
Ikonomidou C., Mosinger J., Shahid Salles K, Olney JW: Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methylaspartate neurotoxicity . J Neurosci1989, in press.
60.
Olney JW, Ikonomidou C., Mosinger JL, Frierdich G.: MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain . J Neurosci1989, in press.
61.
Volpe JJ: Neonatal intraventricular hemorrhage. N Engl J Med1981;304:886-891.
62.
Pearce IA, Cambray-Deakin MA, Burgoyne RD: Glutamate acting on NMDA receptors stimulates neurite outgrowth from cerebellar granule cells. FEBS Lett1987;223:143-147.
63.
Aruffo C., Ferszi R., Hildebrandt AG, Cervos-Navarro J.: Low doses of L-monosodium glutamate promote neuronal growth and differentiation in vitro. Dev Neurosci1987;9:228-239.
64.
Balazs R., Jorgensen OS, Hack N.: N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience1988;27:437-451.